Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of balloon pulmonary angioplasty on the pharmacokinetics of riociguat in CTEPH
jRCT1041200111Recruiting
- Start
- Mar 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of riociguat in chronic thromboembolic pulmonary hypertension (CTEPH). Primary endpoint: Riociguat AUC before and after BPA. Started Mar 2021; status: recruiting.
02
Drugs
riociguat
03
Conditions
chronic thromboembolic pulmonary hypertension (CTEPH)
Beyond the preview
Go deeper on jRCT1041200111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1041200111.